CALC (STOCKS)
CalciMedica, Inc. Common Stock
$0.637900
+0.020100 (+3.25%)
Prev close: $0.617800
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Rachel Anne Leheny
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9.85M
- Employees
- 15
- P/E (TTM)
- -0.32
- P/B (TTM)
- -1.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.73 | $-0.42 | -0.3092 | -73.48% |
|
Sep 2025 (Q3)
|
$-0.52 | $-0.42 | -0.0992 | -23.57% |
|
Jun 2025 (Q2)
|
$-0.40 | $-0.36 | -0.0430 | -12.04% |
|
Mar 2025 (Q1)
|
$-0.36 | $-0.31 | -0.0472 | -15.09% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$6.44M |
| Operating Expenses | $23.12M |
| Research and Development | $15.23M |
| Other Operating Expenses | $7.89M |
| Operating Income/Loss | -$23.12M |
| Income/Loss From Continuing Operations After Tax | -$29.56M |
| Income/Loss From Continuing Operations Before Tax | -$29.56M |
| Income Tax Expense/Benefit | $0.00 |
| Noninterest Income | $713.00K |
| Net Income/Loss | -$29.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$29.56M |
| Net Income/Loss Available To Common Stockholders, Basic | -$29.56M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.97 |
| Diluted Earnings Per Share | -$1.97 |
| Basic Average Shares | 15,011,321 |
| Diluted Average Shares | 15,011,321 |
| Assets | $13.59M |
| Current Assets | $13.53M |
| Cash | $13.00M |
| Other Current Assets | $530.00K |
| Noncurrent Assets | $61.00K |
| Fixed Assets | $50.00K |
| Other Non-current Assets | $11.00K |
| Liabilities | $20.23M |
| Current Liabilities | $3.78M |
| Accounts Payable | $1.16M |
| Other Current Liabilities | $2.62M |
| Noncurrent Liabilities | $16.45M |
| Equity | -$6.64M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$6.64M |
| Liabilities And Equity | $13.59M |
| Net Cash Flow From Operating Activities | -$21.18M |
| Net Cash Flow From Operating Activities, Continuing | -$21.18M |
| Net Cash Flow From Investing Activities | $9.55M |
| Net Cash Flow From Investing Activities, Continuing | $9.55M |
| Net Cash Flow From Financing Activities | $15.21M |
| Net Cash Flow From Financing Activities, Continuing | $15.21M |
| Net Cash Flow | $3.59M |
| Net Cash Flow, Continuing | $3.59M |
| Comprehensive Income/Loss | -$29.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$29.57M |
| Other Comprehensive Income/Loss | -$4.00K |